×
AllNewsShoppingImages Maps Videos Books
Search tools

Revance Names New CEO to Drive Next Phase in Aesthetic Innovation

Global Cosmetics News
Revance Names New CEO to Drive Next Phase in Aesthetic Innovation ... THE WHAT? Revance Therapeutics has announced a leadership succession plan,...
1 month ago

Crown Laboratories Announces Completion of Acquisition of Revance Therapeutics

PR Newswire
Crown Laboratories, Inc. (Crown), a privately held, global innovative leader in the skincare industry, today announced the successful closing of its...
4 months ago

RVNC Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Revance Therapeutics, Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm

ACCESS Newswire
NEW YORK, NY / ACCESSWIRE / January 19, 2022 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against...
5 days ago

Revance Announces Blue Lizard® Australian Sunscreen Times Square Takeover to Celebrate National Sunscreen Day

Morningstar
Revance is a fast-growing global aesthetics and skincare company focused on providing innovative aesthetics and market-leading skincare...
1 month ago

Johnson City-based Crown Labs now operating as ‘Revance’

WJHL
Crown Laboratories, a Johnson City-based skincare and aesthetics producer, will operate under a new name, effective immediately.
2 months ago

REVANCE ALERT: Bragar Eagel & Squire, P.C. is Investigating

GlobeNewswire
Bragar Eagel & Squire, PC is investigating Revance Therapeutics, Inc. on behalf of long-term stockholders and encourages investors to contact the firm.
3 months ago

Revance agrees to lower take-private offer by Crown Labs

Reuters
Crown Laboratories would buy the anti-wrinkle injection maker Revance Therapeutics (RVNC.O) at a roughly 50% lower price compared to an original agreement...
6 months ago

Crown Laboratories rebrands as Revance following acquisition

WCYB
Crown Laboratories announced Monday that it is now operating under the name Revance. This rebranding follows the company's recent acquisition of Revance...
2 months ago

Crown Laboratories Completes Acquisition of Revance Therapeutics

Yahoo Finance
NEW YORK, February 07, 2025--Yesterday, Crown Laboratories, Inc. ("Crown"), a Hildred Capital portfolio company and privately held,...
4 months ago

Revance Therapeutics, Inc. Class Action Lawsuit Alert: Johnson Fistel Announces Shareholders with Losses Should Contact the Law Firm for More Information

Business Wire
The lawsuit seeks to recover losses on behalf of investors who acquired securities between February 29, 2024 and December 6, 2024.
4 months ago